HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors.

Abstract
Intracranial delivery of therapeutic agents is limited by penetration beyond the blood-brain barrier (BBB) and rapid metabolism of the drugs that are delivered. Convection-enhanced delivery (CED) of drug-loaded nanoparticles (NPs) provides for local administration, control of distribution, and sustained drug release. While some investigators have shown that repeated CED procedures are possible, longer periods of sustained release could eliminate the need for repeated infusions, which would enhance safety and translatability of the approach. Here, we demonstrate that nanoparticles formed from poly(ethylene glycol)-poly(ω-pentadecalactone-co-p-dioxanone) block copolymers [PEG-poly(PDL-co-DO)] are highly efficient nanocarriers that provide long-term release: small nanoparticles (less than 100 nm in diameter) continuously released a radiosensitizer (VE822) over a period of several weeks in vitro, provided widespread intracranial drug distribution during CED, and yielded significant drug retention within the brain for over 1 week. One advantage of PEG-poly(PDL-co-DO) nanoparticles is that hydrophobicity can be tuned by adjusting the ratio of hydrophobic PDL to hydrophilic DO monomers, thus making it possible to achieve a wide range of drug release rates and drug distribution profiles. When administered by CED to rats with intracranial RG2 tumors, and combined with a 5-day course of fractionated radiation therapy, VE822-loaded PEG-poly(PDL-co-DO) NPs significantly prolonged survival when compared to free VE822. Thus, PEG-poly(PDL-co-DO) NPs represent a new type of versatile nanocarrier system with potential for sustained intracranial delivery of therapeutic agents to treat brain tumors.
AuthorsEvan M Chen, Amanda R Quijano, Young-Eun Seo, Christopher Jackson, Alexander D Josowitz, Seth Noorbakhsh, Andrea Merlettini, Ranjini K Sundaram, Maria Letizia Focarete, Zhaozhong Jiang, Ranjit S Bindra, W Mark Saltzman
JournalBiomaterials (Biomaterials) Vol. 178 Pg. 193-203 (09 2018) ISSN: 1878-5905 [Electronic] Netherlands
PMID29936153 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 Elsevier Ltd. All rights reserved.
Chemical References
  • Biocompatible Materials
  • Isoxazoles
  • Polyesters
  • Pyrazines
  • Radiation-Sensitizing Agents
  • poly(omega-pentadecalactone-co-p-dioxanone)
  • Polyethylene Glycols
  • berzosertib
Topics
  • Animals
  • Biocompatible Materials (chemistry)
  • Brain Neoplasms (drug therapy, pathology)
  • Convection
  • Drug Delivery Systems
  • Drug Liberation
  • Hydrodynamics
  • Isoxazoles (pharmacology)
  • Male
  • Nanoparticles (chemistry, ultrastructure)
  • Polyesters (chemical synthesis, chemistry)
  • Polyethylene Glycols (chemical synthesis, chemistry)
  • Pyrazines (pharmacology)
  • Radiation-Sensitizing Agents (pharmacology)
  • Rats, Inbred F344
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: